city New Delhi India city Pune covid-19 vaccine infection Coronavirus city New Delhi India city Pune

Bharat Biotech to lead project to develop human antibodies for covid-19 therapy

Reading now: 495
www.livemint.com

NEW DELHI: Bharat Biotech International Ltd will lead a project sanctioned by the Council of Scientific and Industrial Research (CSIR) for developing human monoclonal antibodies as therapy for covid-19 infections, the company said in a release.

This programme—which brings together the National Centre for Cell Science (NCCS) in Pune, and Indian Institute of Technology-Indore and Gurgaon-based startup PredOmix Technologies apart from Bharat Biotech—is aimed at developing an alternate therapeutic regimen by generating effective and specific human monoclonal antibodies that are capable of neutralizing the novel coronavirus - SARS-CoV2. “The question is of how to treat those individuals who are already infected?

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA